Insider · CIK 0001184227
Gilbert S Omenn
Files at GALT (GALECTIN THERAPEUTICS INC), AMST (Amesite Inc.). First filing Jan 8, 2025, latest Jan 8, 2025.
In brief
Gilbert S Omenn files SEC Form 4 as director at AMST (Amesite Inc.), and also at GALT (GALECTIN THERAPEUTICS INC). Since Jan 8, 2025, Gilbert S Omenn has reported 1 open-market buy worth $9,999 and 0 open-market sells worth $0, the latest filed on Jan 8, 2025.
A track record needs three past buys with six months of prices behind them; Gilbert S Omenn has 0, so none is measured yet.
The newest scored trade: bought $9,999 of AMST on Jan 7, 2025, filed Jan 8, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMST: Amesite Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Amesite Inc. | $9,999 3,333 shares | +51% | - |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +12,121 | $0.00 | $0 | 95,927 | 11 d ago |
| Jun 30, 2026 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +9,023 | $0.00 | $0 | 83,806 | Jul 1, 2026 |
| Mar 31, 2026 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +6,522 | $0.00 | $0 | 74,783 | Apr 1, 2026 |
| Mar 7, 2026 | AMST Amesite Inc. | MOption exercise Common Stockindirect: By Gilbert S. Omenn Revocable Trust | +41,322 | - | - | 143,699 | Mar 10, 2026 |
| Mar 7, 2026 | AMST Amesite Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | -41,322 | $0.00 | $0 | 0 | Mar 10, 2026 |
| Feb 6, 2026 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +49,751 | $0.00 | $0 | 49,751 | Feb 10, 2026 |
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 21, 2026 |
| Dec 31, 2025 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +6,349 | $0.00 | $0 | 68,261 | Jan 5, 2026 |
| Sep 30, 2025 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +3,934 | $0.00 | $0 | 61,912 | Oct 2, 2025 |
| Jun 30, 2025 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +4,461 | $0.00 | $0 | 57,978 | Jul 2, 2025 |
| Mar 31, 2025 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +4,959 | $0.00 | $0 | 53,517 | Apr 2, 2025 |
| Mar 31, 2023 | AMST Amesite Inc. | MOption exercise Common Stockindirect: By Gilbert S. Omenn Revocable Trust | +14,620 | - | - | 61,055 | Mar 11, 2025 |
| Mar 7, 2025 | AMST Amesite Inc. | AGrant or award Common Stockindirect: By Gilbert S. Omenn Revocable Trust | +41,322 | - | - | 102,377 | Mar 11, 2025 |
| Mar 31, 2023 | AMST Amesite Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | -14,620 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Mar 7, 2025 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +41,322 | $0.00 | $0 | 41,322 | Mar 11, 2025 |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 27, 2025 |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 27, 2025 |
| Jan 16, 2025 | AMST Amesite Inc. | MOption exercise Common Stockindirect: By Gilbert S. Omenn Revocable Trust | +36,630 | - | - | 46,435 | Jan 16, 2025 |
| Jan 16, 2025 | AMST Amesite Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | -36,630 | $0.00 | $0 | 0 | Jan 16, 2025 |
| Jan 7, 2025 | AMST Amesite Inc. | POpen-market purchase Common Stockindirect: By Gilbert S. Omenn Revocable Trust | +3,333 | $3.00 | $9,999 | 9,805 | Jan 8, 2025 |
| Dec 31, 2024 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +2,526 | $0.00 | $0 | 48,558 | Jan 3, 2025 |
| Jan 24, 2024 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 7, 2024 |
| Jan 16, 2024 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +36,630 | $0.00 | $0 | 36,630 | Jan 18, 2024 |
| Dec 29, 2023 | AMST Amesite Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Gilbert S. Omenn Revocable Trust | +5,333 | $0.00 | $0 | 31,753 | Jan 3, 2024 |
Questions about Gilbert S Omenn
Answered from the filings on this page, as of the latest one.
Is Gilbert S Omenn buying or selling?
Not in the last 12 months. Gilbert S Omenn's latest open-market trade on SEC Form 4 was bought $9,999 of AMST on Jan 7, 2025.
How did Gilbert S Omenn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gilbert S Omenn has 0.
Where does Gilbert S Omenn file Form 4?
Gilbert S Omenn has filed Form 4 at AMST (Amesite Inc.); GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.